ResearcherUniversity of OttawaNo recent work listed

Guillaume Martel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1242-2601; OpenAlex author ID A5057155561. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 13

Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 1 paper

Papers 3

Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research R… Co-author DOI 10.1200/po.17.00098 ↗
The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta-analysis. Co-author DOI 10.1371/journal.pone.0173687 ↗
Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review. Last author DOI 10.1186/s12885-016-2821-0 ↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mišo Gostimir · 1 shared paper, 2016 · strength 0.08
- Paper Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case rep… DOI 10.1186/s12885-016-2821-0 ↗
Sean Bennett · 1 shared paper, 2016 · strength 0.08
- Paper Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case rep… DOI 10.1186/s12885-016-2821-0 ↗
Terence N. Moyana · 1 shared paper, 2016 · strength 0.08
- Paper Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case rep… DOI 10.1186/s12885-016-2821-0 ↗
Paul Damien James · 1 shared paper, 2017 · strength 0.07
- Paper The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta… DOI 10.1371/journal.pone.0173687 ↗
Steven J. Heitman · 1 shared paper, 2017 · strength 0.07
- Paper The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta… DOI 10.1371/journal.pone.0173687 ↗
Spring Holter · 1 shared paper, 2018 · strength 0.06
- Paper Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinic… DOI 10.1200/po.17.00098 ↗
Cavin Wong · 1 shared paper, 2018 · strength 0.06
- Paper Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinic… DOI 10.1200/po.17.00098 ↗
Ashton Anthony Connor · 1 shared paper, 2018 · strength 0.06
- Paper Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinic… DOI 10.1200/po.17.00098 ↗
Ayelet Borgida · 1 shared paper, 2018 · strength 0.06
- Paper Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinic… DOI 10.1200/po.17.00098 ↗
Alyssa L. Smith · 1 shared paper, 2018 · strength 0.06
- Paper Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinic… DOI 10.1200/po.17.00098 ↗
Jeffrey Stewart Barkun · 1 shared paper, 2018 · strength 0.06
- Paper Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinic… DOI 10.1200/po.17.00098 ↗
Steve Gallinger · 1 shared paper, 2018 · strength 0.06
- Paper Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinic… DOI 10.1200/po.17.00098 ↗
George Zogopoulos · 1 shared paper, 2018 · strength 0.06
- Paper Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinic… DOI 10.1200/po.17.00098 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.